113 related articles for article (PubMed ID: 34563340)
1. Early postoperative mortality in liver transplant recipients involving indications other than hepatocellular carcinoma. A retrospective cohort study.
Pozo-Laderas JC; Guler I; Rodríguez-Perálvarez M; Robles JC; Mula A; López-Cillero P; de la Fuente C
Med Intensiva (Engl Ed); 2021 Oct; 45(7):395-410. PubMed ID: 34563340
[TBL] [Abstract][Full Text] [Related]
2. Pretransplant predictors of early mortality in adult recipients of liver transplantation in the MELD-Na Era.
Pozo-Laderas JC; Rodríguez-Perálvarez M; Muñoz-Villanueva MC; Rivera-Espinar F; Durban-García I; Muñoz-Trujillo J; Robles-Arista JC; Briceño-Delgado J
Med Intensiva (Engl Ed); 2019; 43(5):261-269. PubMed ID: 29735173
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
[TBL] [Abstract][Full Text] [Related]
4. Donor factors similarly impact survival outcome after liver transplantation in hepatocellular carcinoma and non-hepatocellular carcinoma patients.
Salgia RJ; Goodrich NP; Marrero JA; Volk ML
Dig Dis Sci; 2014 Jan; 59(1):214-9. PubMed ID: 24077924
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
6. Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation.
Orci LA; Berney T; Majno PE; Lacotte S; Oldani G; Morel P; Mentha G; Toso C
Br J Surg; 2015 Sep; 102(10):1250-7. PubMed ID: 26098966
[TBL] [Abstract][Full Text] [Related]
7. Short- and long-term mortality after liver transplantation in patients with and without hepatocellular carcinoma in the UK.
Wallace D; Cowling TE; Walker K; Suddle A; Rowe I; Callaghan C; Gimson A; Bernal W; Heaton N; van der Meulen J
Br J Surg; 2020 Jun; 107(7):896-905. PubMed ID: 32128793
[TBL] [Abstract][Full Text] [Related]
8. Assessing the Impact of Suboptimal Donor Characteristics on Mortality After Liver Transplantation: A Time-dependent Analysis Comparing HCC With Non-HCC Patients.
Wallace D; Walker K; Charman S; Suddle A; Gimson A; Rowe I; Callaghan C; Cowling T; Heaton N; van der Meulen J
Transplantation; 2019 Apr; 103(4):e89-e98. PubMed ID: 30747843
[TBL] [Abstract][Full Text] [Related]
9. Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.
Chao JS; Zhao SL; Ou-Yang SW; Qian YB; Liu AQ; Tang HM; Zhong L; Peng ZH; Xu JM; Sun HC
World J Gastroenterol; 2019 Oct; 25(37):5630-5640. PubMed ID: 31602163
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.
Yang JD; Larson JJ; Watt KD; Allen AM; Wiesner RH; Gores GJ; Roberts LR; Heimbach JA; Leise MD
Clin Gastroenterol Hepatol; 2017 May; 15(5):767-775.e3. PubMed ID: 28013117
[TBL] [Abstract][Full Text] [Related]
11. Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma.
Yanik EL; Chinnakotla S; Gustafson SK; Snyder JJ; Israni AK; Segev DL; Engels EA
Liver Transpl; 2016 May; 22(5):627-34. PubMed ID: 26784951
[TBL] [Abstract][Full Text] [Related]
12. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
[TBL] [Abstract][Full Text] [Related]
13. Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry.
Sehjal J; Sharples LD; Keogh RH; Walker K; Prachalias A; Heaton N; Ivanics T; van der Meulen J; Wallace D
Transplantation; 2022 Nov; 106(11):e464-e475. PubMed ID: 36017919
[TBL] [Abstract][Full Text] [Related]
14. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
[TBL] [Abstract][Full Text] [Related]
15. Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts.
Croome KP; Wall W; Chandok N; Beck G; Marotta P; Hernandez-Alejandro R
Liver Transpl; 2013 Nov; 19(11):1214-23. PubMed ID: 23907778
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation.
Hoffmann CJ; Subramanian AK; Cameron AM; Engels EA
Transplantation; 2008 Sep; 86(6):784-90. PubMed ID: 18813102
[TBL] [Abstract][Full Text] [Related]
17. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
[TBL] [Abstract][Full Text] [Related]
18. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma.
Maegawa FB; Shehorn L; Aziz H; Kettelle J; Jie T; Riall TS
JAMA Netw Open; 2019 Jan; 2(1):e187142. PubMed ID: 30657533
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation for T3 lesions has higher waiting list mortality but similar survival compared to T1 and T2 lesions.
Schmitt TM; Kumer SC; Shah N; Argo CK; Northup PG
Ann Hepatol; 2010; 9(4):390-6. PubMed ID: 21057157
[TBL] [Abstract][Full Text] [Related]
20. Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation.
Goldaracena N; Gorgen A; Doyle A; Hansen BE; Tomiyama K; Zhang W; Ghanekar A; Lilly L; Cattral M; Galvin Z; Selzner M; Bhat M; Selzner N; McGilvray I; Greig PD; Grant DR; Sapisochin G
J Hepatol; 2019 Apr; 70(4):666-673. PubMed ID: 30630009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
